Tammy Johnston
Family Medicine · Bryson City, NCNPI 1467745513
Payments from drug & device makers
Across 303 payments — averaging $16.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$813
- AbbVie$764
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$648
- GSK$435
- Amgen$392
- Lilly USA, LLC$323
- plus $2K from 26 others
What the payments were for
- Food & beverage$5,01599%
- Education$331%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 56 | $813 |
| AbbVie(2 entities) | 51 | $764 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 30 | $648 |
| GSK | 23 | $435 |
| Amgen | 25 | $392 |
| Lilly USA, LLC | 19 | $323 |
| Pfizer | 17 | $243 |
| AstraZeneca | 12 | $174 |
| Boehringer Ingelheim | 8 | $127 |
| Exact Sciences | 7 | $108 |
| Xeris Pharmaceuticals, Inc. | 6 | $99 |
| Paratek Pharmaceuticals, Inc. | 5 | $97 |
| Johnson & Johnson | 5 | $93 |
| Merck | 6 | $90 |
| Sanofi-aventis U.S. LLC | 4 | $89 |
| Bayer | 5 | $75 |
| Abbott | 3 | $65 |
| Mylan Specialty L.p. | 2 | $41 |
| E.r. Squibb & Sons, L.L.C. | 3 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Astellas Pharma US Inc | 2 | $37 |
| Verona Pharma, Inc. | 1 | $34 |
| Viatris Specialty LLC | 2 | $31 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $29 |
| Inari Medical, Inc. | 1 | $27 |
| Genentech USA, Inc. | 1 | $21 |
| Ironwood Pharmaceuticals, Inc | 1 | $21 |
| Ardelyx, Inc. | 1 | $18 |
| Corcept Therapeutics | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
How this compares
$5,048 in reported general payments places this provider in the 85th percentile of 3,444 family medicine providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 87 | $135,256 |
| EliquisApixaban | 94 | $122,084 |
| MounjaroTirzepatide | 79 | $113,565 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 44 | $56,859 |
| XareltoRivaroxaban | 38 | $50,562 |
| LinzessLinaclotide | 24 | $28,391 |
| JardianceEmpagliflozin | 13 | $22,303 |
| MyrbetriqMirabegron | 13 | $17,231 |
| Breo ElliptaFluticasone/Vilanterol | 16 | $16,502 |
| Repatha SureclickEvolocumab | 17 | $14,965 |
| SymbicortBudesonide/Formoterol Fumarate | 30 | $13,213 |
| PremarinEstrogens, Conjugated | 17 | $10,136 |
| EntrestoSacubitril/Valsartan | 12 | $8,264 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 44 | $7,265 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 203 | $6,823 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $813 | $135,25687 claims |
| PfizerEliquis, Premarin, Paxlovid | $243 | $133,588126 claims |
| Lilly USA, LLCMounjaro | $323 | $113,56579 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $435 | $73,36160 claims |
| Johnson & JohnsonXarelto | $93 | $50,56238 claims |
| AbbVieLinzess, Synthroid | $764 | $32,67299 claims |
| Boehringer IngelheimJardiance | $127 | $22,30313 claims |
| Astellas Pharma US IncMyrbetriq | $37 | $17,23113 claims |
| AstraZenecaSymbicort | $174 | $13,21330 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,444 family medicine providers in North Carolina.
Other family medicine in Bryson City
- Barton WilliamsWilmington$17.3M
- Alexander MurrayGreensboro$13M
- Arin PiramzadianJacksonville$13M
- Jonathan WilsonHickory$12.7M
- George RaadCharlotte$7.7M
- Cecil FarringtonSalisbury$6.4M
- Christian MartinShelby$5.4M
- John EarlHickory$4.7M
- Patrick MorganteHavelock$4.6M
- Stephen JonesShelby$4.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.